Literature DB >> 33227336

Rational design and characterisation of a linear cell penetrating peptide for non-viral gene delivery.

Emma M McErlean1, Monika Ziminska1, Cian M McCrudden1, John W McBride1, Stephen P Loughran1, Grace Cole1, Eoghan J Mulholland1, Vicky Kett1, Niamh E Buckley1, Tracy Robson2, Nicholas J Dunne3, Helen O McCarthy4.   

Abstract

The design of a non-viral gene delivery system that can release a functional nucleic acid at the intracellular destination site is an exciting but also challenging proposition. The ideal gene delivery vector must be non-toxic, non-immunogenic, overcome extra- and intra-cellular barriers, protect the nucleic acid cargo from degradation with stability over a range of temperatures. A new 15 amino acid linear peptide termed CHAT was designed in this study with the goal of delivering DNA with high efficiency into cells in vitro and tissues in vivo. Rational design involved incorporation of key amino acids including arginine for nucleic acid complexation and cellular uptake, tryptophan to enhance hydrophobic interaction with cell membranes, histidine to facilitate endosomal escape and cysteine for stability and controlled cargo release. Six linear peptides were synthesised with strategic sequences and amino acid substitutions. Data demonstrated that all six peptides complexed pDNA to produce cationic nanoparticles less than 200 nm in diameter, but not all peptides resulted in successful transfection; indicating the influence of peptide design for endosomal escape. Peptide 4, now termed CHAT, was non-cytotoxic, traversed the plasma membrane of breast and prostate cancer cell lines, and elicited reporter-gene expression following intra-tumoural and intravenous delivery in vivo. CHAT presents an exciting new peptide for the delivery of nucleic acid therapeutics.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cell penetrating; Gene delivery; Linear peptides; Non-viral; Nucleic acids

Year:  2020        PMID: 33227336     DOI: 10.1016/j.jconrel.2020.11.037

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  7 in total

Review 1.  Biotherapeutic effect of cell-penetrating peptides against microbial agents: a review.

Authors:  Idris Zubairu Sadiq; Aliyu Muhammad; Sanusi Bello Mada; Bashiru Ibrahim; Umar Aliyu Umar
Journal:  Tissue Barriers       Date:  2021-10-25

Review 2.  New approaches to moderate CRISPR-Cas9 activity: Addressing issues of cellular uptake and endosomal escape.

Authors:  Maja van Hees; Sofie Slott; Anders Højgaard Hansen; Heon Seok Kim; Hanlee P Ji; Kira Astakhova
Journal:  Mol Ther       Date:  2021-06-04       Impact factor: 11.454

Review 3.  Anti-Inflammatory microRNAs for Treating Inflammatory Skin Diseases.

Authors:  Shih-Chun Yang; Ahmed Alalaiwe; Zih-Chan Lin; Yu-Chih Lin; Ibrahim A Aljuffali; Jia-You Fang
Journal:  Biomolecules       Date:  2022-08-03

4.  Comparing Variants of the Cell-Penetrating Peptide sC18 to Design Peptide-Drug Conjugates.

Authors:  Joshua Grabeck; Tamara Lützenburg; Pia Frommelt; Ines Neundorf
Journal:  Molecules       Date:  2022-10-07       Impact factor: 4.927

Review 5.  Mesenchymal Stem Cells Engineered by Nonviral Vectors: A Powerful Tool in Cancer Gene Therapy.

Authors:  Yuan Ding; Chenyang Wang; Zhongquan Sun; Yingsheng Wu; Wanlu You; Zhengwei Mao; Weilin Wang
Journal:  Pharmaceutics       Date:  2021-06-21       Impact factor: 6.321

6.  Effect of Plasmid DNA Size on Chitosan or Polyethyleneimine Polyplexes Formulation.

Authors:  J F A Valente; P Pereira; A Sousa; J A Queiroz; F Sousa
Journal:  Polymers (Basel)       Date:  2021-03-05       Impact factor: 4.329

Review 7.  Peptide-Based Nanoparticles for Therapeutic Nucleic Acid Delivery.

Authors:  Prisca Boisguérin; Karidia Konate; Emilie Josse; Eric Vivès; Sébastien Deshayes
Journal:  Biomedicines       Date:  2021-05-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.